These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17184743)

  • 21. Early Abrogation of Gelatinase Activity Extends the Time Window for tPA Thrombolysis after Embolic Focal Cerebral Ischemia in Mice.
    Chen S; Chen Z; Cui J; McCrary ML; Song H; Mobashery S; Chang M; Gu Z
    eNeuro; 2018; 5(3):. PubMed ID: 29963617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats.
    Vyavahare N; Jones PL; Tallapragada S; Levy RJ
    Am J Pathol; 2000 Sep; 157(3):885-93. PubMed ID: 10980128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.
    Leppert D; Lindberg RL; Kappos L; Leib SL
    Brain Res Brain Res Rev; 2001 Oct; 36(2-3):249-57. PubMed ID: 11690622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction.
    Haorah J; Ramirez SH; Schall K; Smith D; Pandya R; Persidsky Y
    J Neurochem; 2007 Apr; 101(2):566-76. PubMed ID: 17250680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve regeneration.
    Demestre M; Wells GM; Miller KM; Smith KJ; Hughes RA; Gearing AJ; Gregson NA
    Neuroscience; 2004; 124(4):767-79. PubMed ID: 15026117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis.
    Leib SL; Clements JM; Lindberg RL; Heimgartner C; Loeffler JM; Pfister LA; Täuber MG; Leppert D
    Brain; 2001 Sep; 124(Pt 9):1734-42. PubMed ID: 11522576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral thermal injury causes blood-brain barrier dysfunction and matrix metalloproteinase (MMP) expression in rat.
    Swann K; Berger J; Sprague SM; Wu Y; Lai Q; Jimenez DF; Barone CM; Ding Y
    Brain Res; 2007 Jan; 1129(1):26-33. PubMed ID: 17156757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury.
    Gu Y; Zheng G; Xu M; Li Y; Chen X; Zhu W; Tong Y; Chung SK; Liu KJ; Shen J
    J Neurochem; 2012 Jan; 120(1):147-56. PubMed ID: 22007835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat.
    Candelario-Jalil E; Taheri S; Yang Y; Sood R; Grossetete M; Estrada EY; Fiebich BL; Rosenberg GA
    J Pharmacol Exp Ther; 2007 Nov; 323(2):488-98. PubMed ID: 17704356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia.
    Cui J; Chen S; Zhang C; Meng F; Wu W; Hu R; Hadass O; Lehmidi T; Blair GJ; Lee M; Chang M; Mobashery S; Sun GY; Gu Z
    Mol Neurodegener; 2012 May; 7():21. PubMed ID: 22587708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse.
    Grossetete M; Rosenberg GA
    J Cereb Blood Flow Metab; 2008 Apr; 28(4):752-63. PubMed ID: 17971790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury.
    Hadass O; Tomlinson BN; Gooyit M; Chen S; Purdy JJ; Walker JM; Zhang C; Giritharan AB; Purnell W; Robinson CR; Shin D; Schroeder VA; Suckow MA; Simonyi A; Sun GY; Mobashery S; Cui J; Chang M; Gu Z
    PLoS One; 2013; 8(10):e76904. PubMed ID: 24194849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases.
    Matyszak MK; Perry VH
    J Neuroimmunol; 1996 Sep; 69(1-2):141-9. PubMed ID: 8823386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury in mice.
    Corbel M; Lanchou J; Germain N; Malledant Y; Boichot E; Lagente V
    Eur J Pharmacol; 2001 Aug; 426(1-2):113-21. PubMed ID: 11525779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier.
    Bonoiu A; Mahajan SD; Ye L; Kumar R; Ding H; Yong KT; Roy I; Aalinkeel R; Nair B; Reynolds JL; Sykes DE; Imperiale MA; Bergey EJ; Schwartz SA; Prasad PN
    Brain Res; 2009 Jul; 1282():142-55. PubMed ID: 19477169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse.
    Semple BD; Noble-Haeusslein LJ; Gooyit M; Tercovich KG; Peng Z; Nguyen TT; Schroeder VA; Suckow MA; Chang M; Raber J; Trivedi A
    PLoS One; 2015; 10(11):e0143386. PubMed ID: 26588471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines.
    Krizanac-Bengez L; Hossain M; Fazio V; Mayberg M; Janigro D
    Am J Physiol Cell Physiol; 2006 Oct; 291(4):C740-9. PubMed ID: 16707552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window.
    Rosenberg GA; Estrada EY; Dencoff JE; Stetler-Stevenson WG
    Brain Res; 1995 Dec; 703(1-2):151-5. PubMed ID: 8719627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of MMP-9 activity following hypoxic ischemia in the developing brain using a highly specific inhibitor.
    Ranasinghe HS; Scheepens A; Sirimanne E; Mitchell MD; Williams CE; Fraser M
    Dev Neurosci; 2012; 34(5):417-27. PubMed ID: 23171520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective gelatinase inhibitor neuroprotective agents cross the blood-brain barrier.
    Gooyit M; Suckow MA; Schroeder VA; Wolter WR; Mobashery S; Chang M
    ACS Chem Neurosci; 2012 Oct; 3(10):730-6. PubMed ID: 23077716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.